Our purpose was to investigate the prognostic value of 18F-FDG PET/CT parameters in
melanoma patients before beginning therapy with antibodies to the programmed cell death …

Purpose An imaging-based stratification tool is needed to identify melanoma patients who
will benefit from anti Programmed Death-1 antibody (anti-PD1). We aimed at identifying …

Purpose To investigate the prognostic value of [18F] FDG PET/CT as part of response
monitoring in metastatic melanoma patients treated with immune checkpoint inhibitors (ICIs) …

Purpose The purpose of this study was to investigate the prognostic value of whole-body
metabolic tumor volume (MTV) and other metabolic tumor parameters, obtained from …

Objective The management of metastatic melanoma remains challenging with only modest
response rates to chemotherapy but the need to identify the best re-staging techniques …

Purpose Investigate the ability of 18 F-fluorothymidine (FLT) PET combined with CT at 6
weeks to predict treatment response at 12 weeks after treatment with pembrolizumab …

Purpose The 2-fluorodeoxyglucose positron emission tomography/computed tomography (2-
[18 F] FDG PET/CT) is used for the evaluation of response to immunotherapy in malignant …

Background Checkpoint inhibitors have drastically improved the therapy of patients with
advanced melanoma. 18F-FDG-PET/CT parameters might act as biomarkers for response …

Purpose In an attempt to identify biomarkers that can reliably predict long-term outcomes to
immunotherapy in metastatic melanoma, we investigated the prognostic role of [18 F] FDG …

Background/Aim: To evaluate the association between baseline [18F] FDG-PET/CT tumor
burden parameters and disease progression rate after first-line target therapy or …